Atlas Trials

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Clinical trial NCT05204602 · UNKNOWN

Trial details

NCT number
NCT05204602
Sponsor
Huashan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19Vaccine ReactionLiver Diseases
Start date
2022-02-10
Primary completion
2022-08-20
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.